Medindia

X

Misonix to Present at Sidoti & Company 2010 Micro Cap Conference

Wednesday, January 6, 2010 Press Release J E 4
Advertisement


FARMINGDALE, N.Y., Jan. 5 Misonix, Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, announced today that Richard Zaremba, Chief Financial Officer, is scheduled to present at the Sidoti & Company 2010 Micro Cap Conference being held in New York City on January 11, 2010. Misonix's presentation is scheduled for 11:10 a.m. EST at the Grand Hyatt New York, located at 109 East 42nd Street at Grand Central Terminal.

Investors will also be able to arrange one-on-one meetings with Richard Zaremba in advance. The exclusive event is available to on-site attendees only. For additional information or to schedule a one-on-one meeting with DARA at this event, please contact Kevin McGrath at kevin@cameronassoc.com/212 245 4577 or Lynn Orenstein at lorenstein@sidoti.com/212 453 7031.

A copy of the management presentation will be posted at: www.misonix.com

About Misonix:

Misonix, Inc. (Nasdaq: MSON) designs, develops, manufactures and markets therapeutic ultrasonic medical devices and laboratory equipment. Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies. Addressing a combined market estimated to be in excess of $3 billion annually; Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications. Additional information is available on the Company's Web site at www.misonix.com.

Investor Relations Contact: Kevin McGrath, Cameron Associates, Inc. 212-245-4577 Kevin@cameronassoc.com

SOURCE Misonix, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
RAD Technology Medical Systems Supports Breastcanc...
S
DiagnoCure to host Q4 2009 and full year earnings ...